Colorectal cancer (CRC) is generally characterized by a high prevalence of Fusobacterium
nucleatum (F. nucleatum), a spindle‐shaped, Gram‐negative anaerobe pathogen derived …

Berberine (BBR), an isoquinoline alkaloid extracted from Coptidis Rhizoma, has a long
history of treating dysentery in the clinic. Over the past two decades, the polytrophic …

Bronchiectasis is marked by bronchial dilatation, recurrent infections and significant
morbidity, underpinned by a complex interplay between microbial dysbiosis and immune …

Antibiotic resistance crisis dictates the need for resistance monitoring and the search for new
antibiotics. The development of monitoring protocols is hindered by the great diversity of …

The host microbiome is polymorphic, compartmentalized, and composed of distinctive tissue
microbiomes. While research in the field of cancer immunotherapy has provided an …

Gut microbiome modulations allow new treatment strategies including the use of
psychobiotics for the treatment and prevention of mood disorders. Well designed clinical …

Introduction This review summarizes our current understanding of the respiratory
microbiome in COPD and Bronchiectasis. We explore the interplay between microbial …

Recent emerging scientific evidence shows a relationship between gut microbiota (GM) and
immunomodulation. In the recently published “Hallmarks of Cancer”, the microbiome has …

In natural microbiomes, microorganisms interact with each other and exhibit diverse
functions. Microbiome engineering, which enables bacterial knockdown, is a promising …

Antimicrobial peptides have the potential to be used in a range of applications, including as
an alternative to conventional antibiotics for the treatment of bacterial infections of humans …